Physical Therapists in Yauco, PR Accepting Medicare
6 Physical Therapists found. Showing 1 - 6
 Alma I Ortiz, MPT,PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 491 Calle Geranio, Hacienda Florida, Yauco, PR 00698 Phone: 939-639-4501 Fax: 787-267-3338 |
Mrs. Annette Rivera, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 516 Calle Neptuno, Urb Vistas De Monte Sol, Yauco, PR 00698 Phone: 787-615-0015 Fax: 787-840-0490 |
Mrs. Maria C Casiano, RPT Physical Therapist Medicare: Medicare Enrolled Practice Location: Urb La Quinta, Calle 1 C 28, Yauco, PR 00698 Phone: 787-455-7824 Fax: 787-267-0234 |
 Rehabibilitacion Ponce De Leon Clinica De Terapia Fisica Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 42 Calle Mattei Lluberas, Suite 1, Yauco, PR 00698 Phone: 787-856-5272 Fax: 787-856-8421 |
 Felix Antonio Cuevas Guzman, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: Vivaldi Pacheco Street, 33, Yauco, PR 00698 Phone: 787-379-2778 |
Mrs. Irma Ponce De Leon Rosado Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 42 Mattei Lluberas, Suite 1, Yauco, PR 00698 Phone: 787-856-5272 Fax: 787-856-8421 |
News Archive
Antibiotic therapy: A potential game-changer for hemodialysis treatment
An antibiotic therapy known to reduce catheter-related bloodstream infections in hemodialysis patients has been shown for the first time to reduce mortality, according to a Henry Ford Health System study.
Taiho receives CHMP positive opinion on Teysuno in combination with cisplatin for advanced gastric cancer
Taiho Pharmaceutical Co., Ltd., and its parent company, Otsuka Holdings Co., Ltd., announced today that the Committee for Medicinal Products for Human Use (CHMP), a division of the European Medicines Agency (EMA), has issued an opinion recommending approval of Teysuno™ (S-1), a novel oral anti-cancer agent, intended for the treatment of advanced gastric cancer in adults when given in combination with cisplatin.
Celera Corporation releases review article on KIF6 gene variant for CHD
Celera Corporation today announced the publication of a review article on the KIF6 gene variant as a predictor of risk of coronary heart disease (CHD) and reduction of CHD events from statin therapy.
New measures to tackle childhood obesity in Britain
Shops may soon be barred from selling energy drinks to children as the UK government gears up to tighten the efforts to curb childhood obesity. Several other proposals have been made to achieve these goals. These include labeling of the calories on the menus, reducing advertising junk foods, stopping free deals on high calorie foods, reduce placement of high calorie foods near store entrances, checkouts and aisles etc.
› Verified 5 days ago
Optometrists
Speech-Language Pathologists
Chiropractors
Physical Therapists
Occupational Therapists